User convenience and multi-layered security strengthen data sharing and collaboration, resulting in a Bluebee platform with a significant competitive edge
LONDON, UK — 20 March 2017 — Based on its recent analysis of the cloud-based genomic solution market, Frost & Sullivan Awards Bluebee Holding BV (Bluebee) the 2017 European Enabling Technology Leadership Award. Bluebee has combined two emerging and disruptive technologies (cloud computing and high performance computing) to develop a secure and accelerated cloud-based genomic data analysis platform that provides high sensitivity and specificity analytics. This platform employs advanced supercomputing techniques to deliver high throughput and rapid genome analysis, while being scalable, secure, cost effective, and commercially applicable.
Optimizing genome analysis for rapid processing speed is often accompanied with a tradeoff in complexity of algorithms. This is not the case for Bluebee which optimizes gold standard algorithms such as BWA and GATK for speed, while guaranteeing identical outcome. Therefore, the Bluebee platform offers faster diagnosis and a predictable turnaround time, regardless of the number of analyses that need to be executed in parallel.
“Bluebee provides preconfigured, validated, and off-the-shelf pipelines that can be used directly on its cloud platform, and at the same time gives users the flexibility to configure their own pipelines,” said Frost & Sullivan Senior Research Analyst Debarati Sengupta. “Bluebee also offers a lift-over service to assist in the migration of an in-house pipeline onto the Bluebee platform. This combination is unique, as it provides a valuable solution in many different scenarios”.
Another unique feature is the platform’s interactive data exploration and visualization tool. The use of the Broad Institute’s Integrative Genomics Viewer presents a smooth online viewing interface of large heterogeneous data sets such as array-based and next-generation sequencing (NGS) data as well as genomic annotations at all levels of the genome resolution.
Bluebee’s exceptional regulatory-compliant platform allows users to store sequencing data and to share results securely in one or a combination of 28 compliant data centres in major European countries, the United States, Canada, and in Asia. This guarantees compliance with data residency requirements, whereby the sensitive genomics data does not leave the data centre in a particular country. The platform segregates and encrypts customer data both in flight and at rest. Digital signing of genomic data files maintains their immutability and authenticity. Additionally, the owner has complete control of the data; Bluebee does not share, use, or access the data.
“Bluebee’s platform allows unlimited scaling up of computing and storage capacity, without requiring upfront investment. Its attractive fee-per-sample business model is all-inclusive, with no additional subscription, maintenance, or licensing costs,” noted Debarati. “Its team of experts provides rapid on-boarding services and hand-held migration of in-house genomic pipelines to aid scientists who are at research and clinical crossroads.”
Bluebee has established its brand value through its growing number of customers and successful collaborations. The company has admirably demonstrated the long-term viability and impact of its genomic solution and has proved itself highly deserving of Frost & Sullivan’s 2017 European Enabling Technology Leadership Award.
Each year, Frost & Sullivan presents this Award to a company that has developed a pioneering technology that enhances current products and enables the development of newer products and applications. The Award recognizes the high market acceptance potential of the recipient’s technology.
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.
Bluebee (www.bluebee.com) provides high performance genomics solutions, enabling genomic labs to substantially reduce cost and time-to-actionable results. Bluebee’s unique cloud-based accelerated genomics platform enables fast, efficient and cost effective processing of large volumes of genomics data. With Bluebee’s private-cloud based solutions, labs can run their pipelines orders of magnitude faster without compromising the algorithms and methods used, nor the flexibility required to provide quality, sensitivity and reliability.
The combination of domain experts in the development and deployment of large scale, mission-critical infrastructure, seasoned bioinformaticians and renowned academic researchers in high-performance computing, led to the use of three disruptive technologies – high performance computing, cloud computing and genomics – which together deliver a unique genome analytics service for research and clinical labs.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, collaborates with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, Frost & Sullivan has been developing growth strategies for the global 1000, emerging businesses, the public sector, and the investment community. Contact us: Start the discussion.
Frost & Sullivan
P: +44 (0) 207 343 8314
P: + 32 475 844917